Professionals 374 results
Capabilities 81 results
Practice Area
Derivatives & Structured Products
Practice Area
Practice Area
Trade Secrets, Non Competes & Restrictive Covenants
Experience 120 results
Experience
|January 29, 2025
Drugs Made In America Acquisition Corp. Announces Closing of $200,000,000 Initial Public Offering
Experience
|January 16, 2025
Winston Wins Dismissal of False Advertising Claims Against Birdseed Manufacturer
Experience
|December 19, 2024
Winston & Strawn Represents Estrella Immunopharma in US$100 Million Shelf Registration
Insights & News 2,481 results
Capital Markets & Securities Law Watch
|April 2, 2025
|3 Min Read
SEC Hosts Roundtable on Artificial Intelligence in Finance
On March 27, 2025, the Securities and Exchange Commission hosted a roundtable discussion on artificial intelligence in the financial industry. Acting Chairman Mark T. Uyeda and Commissioners Hester M. Peirce and Caroline A. Crenshaw delivered remarks that highlighted the SEC’s efforts to assess AI’s evolving role in finance, including its benefits, risks, and regulatory implications.
Client Alert
|March 28, 2025
|3 Min Read
HHS Announces Major Restructuring and Workforce Reductions
On March 27, 2025, citing priorities to reduce agency budget costs and eliminate redundancy among sub-agencies, the U.S. Department of Health and Human Services (HHS) announced that it would be undergoing a significant restructuring, including cutting 20,000 jobs largely from public health agencies.
Sponsorship
|March 27, 2025
Winston & Strawn Sponsors, Partner Speaks at IMN’s HEI & Home Equity Capital Markets Forum 2025
Other Results 76 results
Site Content
Site Content
Site Content
What Are Unfair Trade Practices?